Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Vaccine
|
December 31, 2013
Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine
L J Brown, R C Rosatte, C Fehlner-Gardiner, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells
Diana Lindner, Claudia Arndt, Liliana Rodrigues Loureiro, et al.
International Journal of Molecular Sciences
|
November 13, 2021
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity
Tabea Bartsch, Claudia Arndt, Liliana R Loureiro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group
E Briasoulis, N Pavlidis, C Terret, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
Sofia Perea, José L López-Ribot, Brian L Wickes, et al.
Blood Cancer Journal
|
September 19, 2015
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
R Aliperta, M Cartellieri, A Feldmann, et al.
The Journal of Chemical Physics
|
May 17, 2019
Surface chemistry of 2,3-dibromosubstituted norbornadiene/quadricyclane as molecular solar thermal energy storage system on Ni(111)
U Bauer, L Fromm, C Weiß, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
September 12, 2024
Evaluation of Hearing Loss: Understanding Audiologic Testing to Refine Image Interpretation
William T Malouf, Meagan P Bachmann, Nuwan T Meegalla, et al.
Bulletin Du Cancer
|
July 19, 2001
[Standards, Options and Recommendations for home parenteral or enteral nutrition in adult cancer patients]
S Schneider, M P Blanc-Vincent, G Nitenberg, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Vaccine
|
December 31, 2013
Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine
L J Brown, R C Rosatte, C Fehlner-Gardiner, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells
Diana Lindner, Claudia Arndt, Liliana Rodrigues Loureiro, et al.
International Journal of Molecular Sciences
|
November 13, 2021
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity
Tabea Bartsch, Claudia Arndt, Liliana R Loureiro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group
E Briasoulis, N Pavlidis, C Terret, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
Sofia Perea, José L López-Ribot, Brian L Wickes, et al.
Blood Cancer Journal
|
September 19, 2015
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
R Aliperta, M Cartellieri, A Feldmann, et al.
The Journal of Chemical Physics
|
May 17, 2019
Surface chemistry of 2,3-dibromosubstituted norbornadiene/quadricyclane as molecular solar thermal energy storage system on Ni(111)
U Bauer, L Fromm, C Weiß, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
September 12, 2024
Evaluation of Hearing Loss: Understanding Audiologic Testing to Refine Image Interpretation
William T Malouf, Meagan P Bachmann, Nuwan T Meegalla, et al.
Bulletin Du Cancer
|
July 19, 2001
[Standards, Options and Recommendations for home parenteral or enteral nutrition in adult cancer patients]
S Schneider, M P Blanc-Vincent, G Nitenberg, et al.
Page
of 13